These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8279784)

  • 1. Kinetic concepts in the treatment of breast cancer.
    Surbone A; Norton L
    Ann N Y Acad Sci; 1993 Nov; 698():48-62. PubMed ID: 8279784
    [No Abstract]   [Full Text] [Related]  

  • 2. [Significance of cytostatic drug dose in adjuvant chemotherapy of breast carcinoma].
    Thomssen C
    Geburtshilfe Frauenheilkd; 1996 Jul; 56(7):M102-5. PubMed ID: 8964443
    [No Abstract]   [Full Text] [Related]  

  • 3. Dose intensity in chemotherapy of metastatic breast cancer.
    J Clin Oncol; 1985 Jun; 3(6):889-91. PubMed ID: 3891924
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chemotherapic management of genitomammary tumors].
    Sarría JA; Irigoyen ML; Cismondi B
    Rev Fac Cien Med Univ Nac Cordoba; 1981; 39(1-4):3-16. PubMed ID: 6897122
    [No Abstract]   [Full Text] [Related]  

  • 5. Adjuvant chemotherapy with cyclophosphamide methotrexate and 5-fluorouracil (CMF) in stage II breast cancer in Indian patients.
    Shetty PA; Sarda PK; Majumdar AT; Pai VR; Shinde SR; D'Souza LJ; Pinto JM; Jussawalla DJ
    Indian J Cancer; 1985 Sep; 22(3):239-44. PubMed ID: 3843327
    [No Abstract]   [Full Text] [Related]  

  • 6. Study of chromosome damage in patients with breast cancer treated by two antineoplastic treatments.
    Silva LM; Takahashi CS; Carrara HH
    Teratog Carcinog Mutagen; 2002; 22(4):257-69. PubMed ID: 12111710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perioperative and conventionally timed chemotherapy in operable breast cancer.
    Goldhirsch A
    Recent Results Cancer Res; 1985; 98():106-13. PubMed ID: 3839931
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy.
    Chlebowski RT
    J Natl Cancer Inst; 2010 Jan; 102(2):137. PubMed ID: 20019336
    [No Abstract]   [Full Text] [Related]  

  • 9. [CMF or CAF combination chemotherapy for breast cancer].
    Ota J
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1886-90. PubMed ID: 8978791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclophosphamide, methotrexate, and fluorouracil: still the gold standard?
    Hudis CA
    J Clin Oncol; 1996 Jul; 14(7):1971-3. PubMed ID: 8683226
    [No Abstract]   [Full Text] [Related]  

  • 11. Old school regimen may turn the tide in metastatic breast cancer.
    Gezgen G; Roach EC; Kizilarslanoglu MC; Altundag K
    J BUON; 2011; 16(4):781. PubMed ID: 22331741
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase III randomized comparison of postoperative adjuvant chemotherapy with 2-year oral UFT (uracil/tegafur) versus six-cycle CMF (cyclophosphamide/methotrexate/5-fluorouracil) in high-risk node-negative breast cancer patients.
    Watanabe T
    Jpn J Clin Oncol; 1998 Jan; 28(1):77-80. PubMed ID: 9491146
    [No Abstract]   [Full Text] [Related]  

  • 13. CMF with 5-FU in continuous infusion--a pilot study.
    Franchi F; Pastore C; Seminara P
    Eur J Gynaecol Oncol; 2006; 27(2):204. PubMed ID: 16620075
    [No Abstract]   [Full Text] [Related]  

  • 14. Lessons from the initial adjuvant cyclophosphamide, methotrexate, and fluorouracil studies in operable breast cancer.
    Bonadonna G; Valagussa P; Veronesi U
    J Clin Oncol; 2008 Jan; 26(3):342-4. PubMed ID: 18202404
    [No Abstract]   [Full Text] [Related]  

  • 15. A case of breast carcinoma late metastasis to the kidney.
    Karamouzis MV; Liodantonaki P; Rigatos G
    Am J Clin Oncol; 2006 Apr; 29(2):209-10. PubMed ID: 16601445
    [No Abstract]   [Full Text] [Related]  

  • 16. Sequential methotrexate and 5-FU in CMFP (cyclophosphamide, methotrexate, 5-FU, and prednisone) therapy for breast cancer.
    Cadman EC; Glick JH; Cross J; Horton J; Taylor SG
    Cancer Treat Rep; 1984 Jun; 68(6):877-9. PubMed ID: 6547367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metronomic cyclophosphamide and methotrexate for breast cancer: enhanced efficacy by adding dalteparin and low-dose prednisone?
    Buckman R
    Breast; 2011 Oct; 20(5):483-4. PubMed ID: 21742498
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical evaluation of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) on advanced and recurrent breast cancer. Clinical study group of CMF for breast cancer in Japan].
    Nomura Y; Tominaga T; Adachi I; Koyama H; Fukami A
    Gan To Kagaku Ryoho; 1994 Sep; 21(12):1949-56. PubMed ID: 8085846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant chemotherapy in operable breast cancer: cyclophosphamide, methotrexate, and fluorouracil versus chlorambucil, methotrexate, and fluorouracil--11-year results of Swiss Group for Clinical Cancer Research trial SAKK 27/82.
    Senn HJ; Maibach R; Castiglione M; Jungi WF; Cavalli F; Leyvraz S; Obrecht JP; Schildknecht O; Siegenthaler P
    J Clin Oncol; 1997 Jul; 15(7):2502-9. PubMed ID: 9215818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant chemotherapy for lymph node-negative, estrogen receptor-negative breast cancer: a tale of three trials.
    Albain KS
    J Natl Cancer Inst; 2004 Dec; 96(24):1801-4. PubMed ID: 15601631
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.